Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Sarcopenia | Research article

Weight changes according to treatment in a diverse cohort of breast cancer patients

Authors: Jami Fukui, Kami White, Timothy B. Frankland, Caryn Oshiro, Lynne Wilkens

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

Weight changes are common among breast cancer patients. The majority of studies to date have focused on weight gain after a breast cancer diagnosis and its implications on health in survivors. Fewer studies have examined weight loss and its related characteristics. Weight changes have been reported to be influenced by several factors such as age, treatment, stage and pre-diagnostic weight. We evaluated weight changes during key treatment time points in early stage breast cancer patients.

Methods

We characterized 389 female patients diagnosed in Hawaii with early stage breast cancer from 2003 to 2017 in the Multiethnic Cohort (MEC) linked with Kaiser Permanente Hawaii electronic medical record data. We evaluated weight changes from surgery to 4 years post-diagnosis with six time points along a patient’s treatment trajectory (chemotherapy, radiation, endocrine, or surgery alone) and annually thereafter, adjusting for age, race/ethnicity and initial body mass index (BMI).

Results

We found key time points of significant weight change for breast cancer patients according to their adjuvant treatment. In patients who had surgery alone (S), surgery-radiation (SR), or surgery-endocrine therapy (SE), the majority of patients had stable weight, although this consistently decreased over time. However, the percentages of patients with weight loss and weight gain during this time steadily increased up to 4 years after initial surgery. Weight loss was more common than weight gain by about 2 fold in these treatment groups. For patients with surgery-chemotherapy (SC), there was significant weight loss seen within the first 3 months after surgery, during the time when patients receive chemotherapy. And this weight loss persisted until year 4. Weight gain was less commonly seen in this treatment group.

Conclusions

We identified key time points during breast cancer treatment that may provide a therapeutic window to positively influence outcomes. Tailored weight management interventions should be utilized to promote overall health and long term survivorship.
Literature
19.
go back to reference Yang J, Schupp CS, Harrati A, et al. Developing an area-based socioeconomic measures from American community survey data. Fremont: Cancer Prevention Institute of California; 2014. Yang J, Schupp CS, Harrati A, et al. Developing an area-based socioeconomic measures from American community survey data. Fremont: Cancer Prevention Institute of California; 2014.
26.
go back to reference Vincent F, Deluche E, Boniset J, et al. Home-based physical activity in patients with breast cancer during and/or after chemotherapy impact on cardiorespiratory fitness. A 3-Arm randomized controlled trial (APAC). Integr Cancer Ther. 2020. https://doi.org/10.1177/1534735420969818. Vincent F, Deluche E, Boniset J, et al. Home-based physical activity in patients with breast cancer during and/or after chemotherapy impact on cardiorespiratory fitness. A 3-Arm randomized controlled trial (APAC). Integr Cancer Ther. 2020. https://​doi.​org/​10.​1177/​1534735420969818​.
28.
go back to reference van Wart H, Stuiver MM, van Harten WH, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33(17):1918–27. https://doi.org/10.1200/JCO.2014.59.1081.CrossRef van Wart H, Stuiver MM, van Harten WH, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33(17):1918–27. https://​doi.​org/​10.​1200/​JCO.​2014.​59.​1081.CrossRef
Metadata
Title
Weight changes according to treatment in a diverse cohort of breast cancer patients
Authors
Jami Fukui
Kami White
Timothy B. Frankland
Caryn Oshiro
Lynne Wilkens
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08740-5

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine